MANFREDI, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 58
AS - Asia 40
NA - Nord America 38
Totale 136
Nazione #
US - Stati Uniti d'America 36
IT - Italia 29
SE - Svezia 19
CN - Cina 18
SG - Singapore 12
RU - Federazione Russa 5
JP - Giappone 4
IL - Israele 3
IE - Irlanda 2
CA - Canada 1
DE - Germania 1
DO - Repubblica Dominicana 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
NL - Olanda 1
Totale 136
Città #
Ashburn 12
Singapore 10
Rome 9
Shanghai 7
Milan 5
Lawrence 4
Moscow 4
Princeton 4
Cantù 3
Ibaraki 3
Kfar Saba 3
Boardman 2
Burolo 2
Chaoyang 2
Dublin 2
Guangzhou 2
New York 2
Washington 2
Beijing 1
Central 1
Ikoma 1
Jiaxing 1
Kashan 1
Monza 1
Ottawa 1
Pune 1
Shenzhen 1
Zaragoza 1
Totale 88
Nome #
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 33
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies 28
Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells 20
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 17
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 15
T-N/SCM Pre-Selection Generates CAR T Cell Products Driving Superior Anti-Tumor Responses While Curtailing Severe CRS 14
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals 14
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 6
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 2
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 1
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 1
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 1
Totale 152
Categoria #
all - tutte 2.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/202222 0 0 0 1 0 0 0 4 8 1 3 5
2022/202343 8 8 5 1 3 5 1 2 5 3 1 1
2023/202448 0 0 4 8 6 7 0 7 2 1 5 8
2024/202538 11 5 7 9 6 0 0 0 0 0 0 0
Totale 152